Improved Prognosis and Low Failure Rate with Anticoagulation as First‐Line Therapy in Mesenteric Venous Thrombosis
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Background: Monotherapy with anticoagulation has been considered as first‐line therapy in patients with mesenteric venous thrombosis (MVT). The aim of this study was to evaluate outcome, prognostic factors, and failure rate of anticoagulation as monotherapy, and to identify when bowel resection was needed. Methods: Retrospective study of consecutive patients with MVT diagnosed between 2000 and 2015. Results: The overall incidence rate of MVT was 1.3/100,000 person‐years. Among 120 patients, seven died due to autopsy‐verified MVT without bowel resection and 15 underwent immediate bowel resection without prior anticoagulation therapy. The remaining 98 patients received anticoagulation monotherapy, whereof 83 (85%) were treated successfully. Fifteen patients failed on anticoagulation monotherapy, of whom seven underwent bowel resection and eight endovascular therapy. Endovascular therapy was followed by bowel resection in three patients. Two late bowel resections were performed due to intestinal stricture. The 30‐day mortality rate was 19.0% in the former (2000–2007) and 3.2% in the latter (2008–2015) part of the study period (p = 0.006). Age ≥75 years (OR 12.4, 95% CI [2.5–60.3]), management during the former as opposed to the latter time period (OR 8.4, 95% CI [1.3–54.7]), and renal insufficiency at admission (OR 8.0, 95% CI [1.2–51.6]) were independently associated with increased mortality in multivariable analysis. Conclusions: Short‐term prognosis in patients with MVT has improved. Contemporary data show that monotherapy with anticoagulation is an effective first choice in MVT patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Editor's Choice – Management of the Diseases of Mesenteric Arteries and Veins
Björck, M., Koelemay, M., Acosta, S., Bastos Goncalves, F., Kölbel, T., Kolkman, J. J., Lees, T., Lefevre, J. H., Menyhei, G., Oderich, G., et al. (2017) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2017.01.010 · Cited by 658
Self-citationCondat, B., Pessione, F., Denninger, M. H., Hillaire, S., & Valla, D. (2000) · Hepatology · doi:10.1053/jhep.2000.16597 · Cited by 492 · cited 1×
“Corroborating other reports [18, 19], the present study showed that a non-operative approach with immediate anticoagulation therapy with unfractionated or low molecular weight heparin at the time of diagnosis was an effective treatment for acute MVT.”
ResultEpidemiology, risk and prognostic factors in mesenteric venous thrombosis
Acosta, S., Alhadad, A., Svensson, P., & Ekberg, O. (2008) · British Journal of Surgery · doi:10.1002/bjs.6319 · Cited by 288
Self-citationMesenteric venous thrombosis: A changing clinical entity
Morasch, M. D., Ebaugh, J. L., Chiou, A. C., Matsumura, J. S., Pearce, W. H., & Yao, J. S. T. (2001) · Journal of Vascular Surgery · doi:10.1067/mva.2001.116965 · Cited by 231 · cited 1×
“as the first-line treatment option [5].”
Hmoud, B., Singal, A. K., & Kamath, P. S. (2014) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2014.03.052 · Cited by 160
Portal vein thrombosis, revisited
Primignani, M. (2010) · Digestive and Liver Disease · doi:10.1016/j.dld.2009.08.003 · Cited by 146 · cited 1×
“CT features such as extensive thrombosis and ascites seem to be predictive factors of poor recanalization on anticoagulant therapy [20].”
BackgroundAcosta, S. (2015) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000189 · Cited by 111
Self-citationMesenteric venous thrombosis with transmural intestinal infarction: A population-based study
Acosta, S., Ögren, M., Sternby, N.-H., Bergqvist, D., & Björck, M. (2005) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2004.10.011 · Cited by 96
Self-citationHenes, F. O., Pickhardt, P. J., Herzyk, A., Lee, S. J., Motosugi, U., Derlin, T., Lubner, M. G., Adam, G., Schön, G., & Bannas, P. (2017) · Abdominal Radiology · doi:10.1007/s00261-016-0988-0 · Cited by 48 · cited 1×
“CT with intravenous contrast and imaging in the portal phase is clearly the most accurate method of diagnosing the condition [17].”
MethodThe role of endovascular therapy in acute mesenteric ischemia
Ierardi, A. M. (2017) · Annals of Gastroenterology · doi:10.20524/aog.2017.0164 · Cited by 37 · cited 1×
“In similar future studies, in which a larger proportion of patients will likely receive endovascular therapy [12], it would be preferable to not only report on therapy-related major bleeding complications, thrombotic events, bowel necrosis, and mortality.”
Background
Research works printed but not linked: 10
- 10.1007/s10140‐009‐0807‐9 · DOI
- 10.1093/eurheartj/ehr134 · DOI · Paper page
- 10.1007/s11605‐009‐1130‐1 · DOI · Paper page
- 10.1056/NEJMra1700365 · DOI · Paper page
- Hakoum MB, 2018, Anticoagulation for the initial treatment of venous thromboembolism in people with cancer, Cochrane Database Syst Rev, 1, 006649
- 10.1001/jamainternmed.2015.3184 · DOI · Paper page
- 10.1046/j.1365‐2796.1997.00178.x · DOI · Paper page
- 10.1186/s12872‐016‐0215‐5 · doi:10.1186/s12872-016-0215-5
- 10.1016/j.ejvs.2015.02.007 · DOI · Paper page
- 10.1053/gast.2001.21209 · DOI · Paper page
Cited by
Koelemay, M. J., Geelkerken, R. H., Kärkkäinen, J., Leone, N., Antoniou, G. A., de Bruin, J. L., Gombert, A., Gottsätter, A., Iborra, E., Ronchey, S., et al. (2025) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2025.06.010 · Cited by 123
Incidence and outcomes of acute mesenteric ischaemia: a systematic review and meta-analysis
Tamme, K., Reintam Blaser, A., Laisaar, K.-T., Mändul, M., Kals, J., Forbes, A., Kiss, O., Acosta, S., Bjørck, M., & Starkopf, J. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-062846 · Cited by 112
Self-citationManagement of Acute Mesenteric Venous Thrombosis: A Systematic Review of Contemporary Studies
Acosta, S., & Salim, S. (2021) · Scandinavian Journal of Surgery · doi:10.1177/1457496920969084 · Cited by 66
“Until further evidence is available, endovascular therapy should be performed in experienced centers in patients that clinically deteriorate during anticoagulation therapy (25) in order to avoid explorative laparotomy and bowel resection.”
BackgroundInfluentialSelf-citationPredictors of Mortality in Acute Mesenteric Ischemia: A Systematic Review and Meta-Analysis.
Sumbal, R., Ali Baig, M. M., & Sumbal, A. (2022) · Journal of Surgical Research · doi:10.1016/j.jss.2022.01.022 · Cited by 33
Metadata
- Authors
- Salim, S., Zarrouk, M., Elf, J., Gottsäter, A., Ekberg, O., & Acosta, S.
- Venue
- World Journal of Surgery
- Publisher
- Wiley
- Published
- 2018-05-17
- Volume
- 42
- Issue
- 11
- Pages
- 3803-3811
- ISSN
- 0364-2313 (ISSN-L)
- 1432-2323
- OpenAlex
- W2804461771
- Cited by
- 24
- References
- 10
- FWCI
- 1.65
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- creativecommons.org/licenses/by/4.0/ (vor)
- creativecommons.org/licenses/by/4.0 (tdm)
- Funders
- Scandinavian Research Foundation for Venous Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.